Antagonizing canonical Wnt signaling pathway by recombinant human sFRP4 purified from E. coli and its implications in cancer therapy
Crossref DOI link: https://doi.org/10.1007/s11010-016-2738-6
Published Online: 2016-06-23
Published Print: 2016-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ghoshal, Archita
Ghosh, Siddhartha Sankar
Funding for this research was provided by:
Department of Biotechnology, Ministry of Science and Technology (BT/PR13560/COE/34/44/2015)
License valid from 2016-06-23